目錄:MedChemExpress LLC>>生化試劑>> Cefepime | MCE
CAS | 88040-23-7 | 純度 | 99.78% |
---|---|---|---|
分子量 | 480.56 | 分子式 | C??H??N?O?S? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 100 mg |
貨號 | HY-B0692 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務(wù)。
CAS No. : 88040-23-7
產(chǎn)品活性:Cefepime (BMY-28142) is a broad-spectrum and cross the blood-brain barrier cephalosporin. Cefepime shows antibacterial effects against both Gram-positive and Gram-negative aerobic bacteria. Cefepime induces neurotoxicity.
研究領(lǐng)域:Anti-infection
作用靶點:Antibiotic | Bacterial
In Vitro: Cefepime chloride exerts its antibacterial effects by binding to penicillin-binding proteins.
In Vivo: Cefepime (80 mg/kg; i.p.) significantly increases the half-life and mice surviveed.
相關(guān)產(chǎn)品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Anti-Infection Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | CNS-Penetrant Compound Library | Drug Repurposing Compound Library | Antibacterial Compound Library | NMPA-Approved Drug Library | FDA Approved & Pharmacopeial Drug Library | Antibiotics Library | Drug-Induced Liver Injury (DILI) Compound Library | Rare Diseases Drug Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Heterocyclic Compound Library | (1R,2S,7R)-Sitafloxacin-d4 (hydrochloride) | Nebacumab | Doxorubicin-13C,d3 (TFA) | Gepotidacin | Amycolatopsin A | Antibiotic A-33853 | Estradiol hemihydrate | Sulbactam-d2 (sodium) | Antimicrobial agent-5 | NBTIs-IN-4 | Proanthocyanidin | Azlocillin sodium salt | Antitubercular agent-13 | Toyocamycin | Lenampicillin hydrochloride | Hispolon | SPR206 acetate | Caracemide | Antimicrobial agent-10 | Doxycycline calcium | Staurosporine | Dihydrostreptomycin sulfate | Ciclopirox olamine | Rubropunctamine | Topoisomerase IV inhibitor 2 | Psoracorylifol C | WX-081 | SQ109 | Ethyl Orsellinate | Indolicidin acetate
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標記物 | 寡核苷酸 | 抗體 | 點擊化學
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種全球僅有化合物庫,我們致力于為全球科研客戶提供前沿的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng);
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā)、生命科學等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學分析檢測分析,藥物篩選等專業(yè)技術(shù)服務(wù);
• 設(shè)有專業(yè)的實驗中心和嚴格的質(zhì)控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團隊跟蹤最新的制藥及生命科學研究進展,為您提供全球新的活性化合物;
• 與世界各大制藥公司及著名科研機構(gòu)建立了長期的合作。